Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Insulin Glargine Injection in shortage?

Insulin Glargine Injection is listed by FDA as being discontinued by at least one maker (updated Oct 24, 2025).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Basaglar, Injection, U-100 Tempo Pen (NDC 0002-8214-05)
    Eli Lilly and Co.Being discontinuedUpdated Oct 24, 2025Discontinued Oct 24, 2025

    A business decision was made to discontinue manufacture of the drug.

    Maker contact: 800-545-5979

Insulin Glargine Injection shortage questions

Is Insulin Glargine Injection in shortage?

Insulin Glargine Injection is listed by FDA as being discontinued by at least one maker (updated Oct 24, 2025).

What should I do if I can’t get Insulin Glargine Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.